CIBC World Market
ASND icon

CIBC World Market’s Ascendis Pharma A/S ASND Stock Holding History

CIBC World Market’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
6,156
-225
-4% -$52.6K ﹤0.01% 902
2026
Q1 		$1.46M Buy
6,381
+20
+0.3% +$4.48K ﹤0.01% 828
2025
Q4 		$1.36M Buy
6,361
+193
+3% +$39.9K ﹤0.01% 863
2025
Q3 		$1.23M Buy
+6,168
New +$1.15M ﹤0.01% 885

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CIBC World Market's ASND Position: Q2 2026 in Review

CIBC World Market reduced its Ascendis Pharma A/S (ASND) stake by 3.5% in Q2 2026, selling an estimated $52.6K and leaving 6,156 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #902.

CIBC World Market first reported a position in ASND in Q3 2025 and has held it in 4 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • CIBC World Market held 6,156 shares of Ascendis Pharma A/S worth $1.64M as of Q2 2026.
  • CIBC World Market sold 225 Ascendis Pharma A/S shares in Q2 2026, an estimated $52.6K.
  • Ascendis Pharma A/S made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #902 holding.
  • CIBC World Market first reported a position in Ascendis Pharma A/S in Q3 2025 and has held it in 4 quarters since.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.